The supernumerary cat eye syndrome (CES) chromosome is dicentric, containing two copies of 22pter→q11.2. We have found that the duplication breakpoints are clustered in two intervals. The more proximal, most common interval is the 450–650 kb region between D22S427 and D22S36, which corresponds to the proximal deletion breakpoint interval found in the 22q11 deletion syndrome (DiGeorge/velocardiofacial syndrome). The more distal duplication breakpoint interval falls between CRKL and D22S112, which overlaps with the common distal deletion interval of the 22q11 deletion syndrome. We have therefore classified CES chromosomes into two types based on the location of the two breakpoints required to generate them. The smaller type I CES chromosomes are symmetrical, with both breakpoints located within the proximal interval. The larger type II CES chromosomes are either asymmetrical, with one breakpoint located in each of the two intervals, or symmetrical, with both breakpoints located in the distal interval. The co-localization of the breakpoints of these different syndromes, plus the presence of low-copy repeats adjacent to each interval, suggests the existence of several specific regions of chromosomal instability in 22q11.2 which are involved in the production of both deletions and duplications. Since the phenotype associated with the larger duplication does not appear to be more severe than that of the smaller duplication, determination of the type of CES chromosome does not currently have prognostic value.

1.
Blinder MA, Marasa JC, Reynolds CH, Deaven LL, Tollefsen DM: Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli. Biochemistry 27:752–759 (1988).
2.
Budarf ML, Eckman B, Michaud D, McDonald T, Gavigan S, Buetow KH, Tatsumura Y, Liu Z, Hilliard C, Goldmuntz E, Messe E, Zwarthoff EC, Williams S, McDermid H, Dumanski JP, Biegel J, Bell CJ, Emanuel BS: Regional localization of over 300 loci on human chromosome 22 using a somatic cell hybrid mapping panel. Genomics 35:275–288 (1996).
3.
Budarf ML, McDermid HE, Sellinger B, Emanuel BS: Isolation and regional localization of 35 unique anonymous DNA markers for human chromosome 22. Genomics 10:996–1002 (1991).
4.
Carey AH, Kelly D, Halford S, Wadey R, Wilson D, Goodship J, Burn J, Paul T, Sharkey A, Dumanski J, Nordenskjold M, Williamson R, Scambler PJ: Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J hum Genet 51:964–970 (1992).
5.
Carey AH, Roach S, Williamson R, Dumanski JP, Nordenskjold M, Collins VP, Rouleau G, Blin N, Jalbert P, Scambler PJ: Localization of 27 DNA markers to the region of human chromosome 22q11-pter deleted in patients with the DiGeorge syndrome and duplicated in the der22 syndrome. Genomics 7:299–306 (1990).
6.
Carlson C, Papolos D, Pandita RK, Faedda GL, Veit S, Goldberg R, Shprintzen R, Kucherlapati R, Morrow B: Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am J hum Genet 60:851–859 (1997).
7.
Chance PF, Abbas N, Lensch MW, Pentao L, Roa BB, Patel PI, Lupski JR: Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum molec Genet 3:223–228 (1994).
8.
Chen K-S, Manianm P, Koeuth T, Potocki L, Zhou Q, Chinault AC, Lee CC, Lupski JR: Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nature Genet 17:154–163 (1997).
9.
Cheng S-D, Spinner NB, Zackai EH, Knoll JHM: Cytogenetic and molecular characterization of inverted duplicated chromosomes 15 from 11 patients. Am J hum Genet 55:753–759 (1994).
10.
Christian SL, Robinson WP, Huang B, Mutirangura A, Line MR, Nakao M, Surti U, Chakravarti A, Ledbetter DH: Molecular characterization of two proximal deletion breakpoint regions in both Prader-Willi and Angelman syndrome patients. Am J hum Genet 57:40–48 (1995).
11.
Collins JE, Cole CG, Smink LJ, Garrett CL, Leversha MA, Soderlund CA, Maslen GL, Everatt LA, Rice KM, Coffey AJ, Gregary SG, Gwilliam R, Dunham A, Davies AF, Hassock S, Todd CM, Lehrach H, Hulsebos TJM, Weissenbach J, Morrow B, Kucherlapati RS, Wadey R, Scambler PJ, Kim U-J, Simon MI, Peyrard M, Xie Y-G, Carter NP, Durbin R, Dumanski JP, Bentley DR, Dunham I: A high-density YAC contig map of human chromosome 22. Nature 377(Suppl 6547):367–379 (1995).
12.
Collins JE, Mungall AJ, Badcock KL, Fay JM, Dunham I : Erratum: The organization of the gamma-glutamyl transferase genes and other low copy repeats in human chromosome 22q11. Genome Res 7:942 (1997a).
13.
Collins JE, Mungall AJ, Badcock KL, Fay JM, Dunham I: The organization of the gamma-glutamyl transferase genes and other low copy repeats in human chromosome 22q11. Genome Res 7:522–531 (1997b).
14.
Crolla JA, Howard P, Mitchell C, Long FL, Dennis NR: A molecular and FISH approach to determining karyotype and phenotype correlations in six patients with supernumerary marker(22) chromosomes. Am J med Genet 72:440–447 (1997).
15.
de Jong PJ, Yokobata K, Chen C, Lohman F, Pederson L, McNinch J, Van Dilla M: Human chromosome-specific partial digest libraries in lambda and cosmid vectors, in HGM10 (1989): Tenth International Workshop on Human Gene Mapping. Cytogenet Cell Genet 51:985 (1989).
16.
Donlon TA, Lalande M, Wyman A, Bruns G, Latt SA: Isolation of molecular probes associated with the chromosome 15 instability in the Prader-Willi syndrome. Proc natl Acad Sci, USA 83:4408–4412 (1986).
17.
Driscoll DA, Budarf ML, Emanuel BS: A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am J hum Genet 50:924–933 (1992a).
18.
Driscoll DA, Spinner NB, Budarf ML, McDonald-McGinn DM, Zackai EH, Goldberg RB, Shprintzen RJ, Saal HM, Zonana J, Jones MC, Mascarello JT, Emanuel BS: Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J med Genet 44:261–268 (1992b).
19.
Driscoll DA, Li M, Chien P, Capuano S, Zackai EH, McDonald-McGinn DM, Christensen KM, Cuneo BF, Saal HM, Gold R, Spector EB, Emanuel BS, Budarf ML: Familial 22q11 deletions: phenotypic variability and determination of deletion boundaries by FISH. Am J hum Genet 57:A33 (1995).
20.
Driscoll DA, Emanuel BS: DiGeorge and velocardiofacial syndromes: the 22q11 deletion syndrome. Ment Retard Dev Disabil Res Rev 2:130–138 (1996).
21.
Dumanski JP, Guerts van Kessel AH, Ruttledge M, Wladis A, Sugawa N, Collins VP, Nordenskjold M: Isolation of anonymous, polymorphic DNA fragments from human chromosome 22q12-qter. Hum Genet 84:219–222 (1990).
22.
Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J: The 1993–94 Généthon human genetic linkage map [see comments]. Nature Genet 7(Spec No 2):246–339 (1994).
23.
Huang B, Crolla JA, Christian SL, Wolf-Ledbetter ME, Macha ME, Papenhausen PN, Ledbetter DH: Refined molecular characterization of the breakpoints in small inv dup(15) chromosomes. Hum Genet 99:11–17 (1997).
24.
Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec PS, Lasseter VK, Eisen H, Childs B, Kazazian HH, Kucherlapati R, Antonarakis SE, Pulver AE, Housman DE: Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc natl Acad Sci, USA 92:7612–7616 (1995).
25.
Kawasaki K, Minoshima S, Schooler K, Kudoh J, Asakawa S, de Jong PJ, Shimizu N: The organization of the human immunoglobulin lambda gene locus. Genome Res 5:125–135 (1995).
26.
Kelly D, Goldberg R, Wilson D, Lindsay E, Carey A, Goodship J, Burn J, Cross I, Shprintzen RJ, Scambler PJ: Confirmation that the velo-cadio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11. Am J med Genet 45:308–312 (1993).
27.
Knoll JHM, Nicholls RD, Magenis RE, Glatt K, Graham JM, Kaplan L, Lalande M: Angelman syndrome: three molecular classes identified with chromosome 15q11q13-specific DNA markers. Am J hum Genet 47:149–155 (1990).
28.
Libert F, Parmentier M, Lefort M, Dinsart C, Van Sande J, Maenhaut C, Simons MJ, Dumont JE, Vassart G: Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science 244:569–572 (1989).
29.
Lichter P, Cremer T, Borden J, Manuelidis L, Ward DC: Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum Genet 80:224–234 (1988).
30.
Magenis RE, Sheehy RR, Brown MG, McDermid HE, White BN, Zonana J, Weleber R: Parental origin of the extra chromosome in the cat eye syndrome: evidence from heteromorphism and in situ hybridization analysis. Am J med Genet 29:9–19 (1988).
31.
McDermid HE, Budarf ML, Emanuel BS: Long-range restriction map of human chromosome 22q11-22q12 between the lambda immunoglobulin locus and the Ewing sarcoma breakpoint. Genomics 18:308–318 (1993).
32.
McDermid HE, Duncan AM, Brasch KR, Holden JJ, Magenis E, Sheehy R, Burn J, Kardon N, Noel B, Schinzel A, Teshima I, White BN: Characterization of the supernumerary chromosome in cat eye syndrome. Science 232:646–648 (1986).
33.
McDermid HE, McTaggart KE, Riazi MA, Hudson TJ, Budarf ML, Emanuel BS, Bell CJ: Long-range mapping and construction of a YAC contig within the cat eye syndrome critical region. Genome Res 6:1149–1159 (1996).
34.
Mears AJ: Molecular characterization of duplications associated with cat eye syndrome. PhD thesis, University of Alberta, Edmonton (1995).
35.
Mears AJ, Duncan AM, Budarf ML, Emanuel BS, Sellinger B, Siegel-Bartelt J, Greenberg CR, McDermid HE: Molecular characterization of the marker chromosome associated with cat eye syndrome. Am J hum Genet 55:134–142 (1994).
36.
Mears AJ, el-Shanti H, Murray JC, McDermid HE, Patil SR: Minute supernumerary ring chromosome 22 associated with cat eye syndrome: further delineation of the critical region. Am J hum Genet 57:667–673 (1995).
37.
Mignon C, Malzac P, Moncla A, Depetris D, Roeckel N, Croquette M-F, Mattei M-G: Clinical heterogeneity in 16 patients with inv dup 15 chromosome: cytogenetic and molecular studies, search for an imprinting effect. Eur J Hum Genet 4: 88–100 (1996).
38.
Morrow B, Goldberg R, Carlson C, Das Gupta R, Sirotkin H, Collins J, Dunham I, O’Donnell H, Scambler P, Shprintzen R, Kucherlapati R: Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am J hum Genet 56:1391–1403 (1995).
39.
Newton MS, Cunningham C, Jacobs PA, Price WH, Fraser IA: Chromosome survey of a hospital for the mentally subnormal. II. Autosome abnormalities. Clin Genet 3:226–248 (1972).
40.
Patel PI, Lupski JR: Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease. Trends Genet 10:128–133 (1994).
41.
Purandare SM, Patel PI: Recombination hot spots and human disease. Genome Res 7:773–786 (1997).
42.
Rosenfeld W, Verma RS, Jhaveri RC: Cat-eye syndrome with unusual marker chromosome probably not chromosome 22. Am J med Genet 18:19–24 (1984).
43.
Schinzel A, Schmid W, Fraccaro M, Tiepolo L, Zuffardi O, Opitz JM, Lindsten J, Zetterquvist P, Enell H, Baccichetti C, Tenconi R, Pagon RA: The cat eye syndrome: dicentric small marker chromosome probably derived from a No. 22 (tetrasomy 22pter to q11) associated with a characteristic phenotype. Report of 11 patients and delineation of the clinical picture. Hum Genet 57:148–158 (1981).
44.
Schreck RR, Breg WR, Erlanger BF, Miller OJ: Preferential derivation of abnormal human G-group-like chromosomes from chromosome 15. Hum Genet 36:1–12 (1977).
45.
Spinner NB, Eunpu DL, Schmickel RD, Zackai EH, McEldrew D, Bunin GR, McDermid H, Emanuel BS: The role of cytologic NOR variants in the etiology of trisomy 21. Am J hum Genet 44:631–638 (1989).
46.
Stewart GD, Harris P, Galt J, Ferguson-Smith MA: Cloned DNA probes regionally mapped to human chromosome 21 and their use in determining the origin of nondisjunction. Nucl Acids Res 13:4125–4132 (1985).
47.
Sutherland GR, Baker E, Hyland VJ, Callen DF, Stahl J, Gough NM: The gene for human leukemia inhibitory factor (LIF) maps to 22q12. Leukemia 3:9–13 (1989).
48.
ten Hoeve J, Morris C, Heisterkamp N, Groffen J: Isolation and chromosomal localization of CRKL, a human crk-like gene. Oncogene 8:2469–2474 (1993).
49.
Tupler R, Hoeller A, Pezzolo A, Maraschio P: Maternal derivation of inv dup (22) and clinical variation in cat-eye syndrome. Annls Génét 37:153–155 (1994).
50.
Van Dyke DL, Weiss L, Logan M, Pai GS: The origin and behavior of two isodicentric bisatellited chromosomes. Am J hum Genet 29:294–300 (1977).
51.
Wilcoxon F: Individual comparisons by ranking methods. Biomet Bull 1:80–83 (1945).
52.
Wilcoxon F, Wilcox RA: Some Rapid Approximate Statistical Procedures (American Cyanamid, Pearl River 1964).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.